How to Get Help for Rheumatology

Navigating rheumatologic care requires understanding which professionals treat inflammatory and autoimmune conditions, how to locate appropriate resources, and what financial assistance programs exist for patients facing high medication costs. Rheumatic diseases — including rheumatoid arthritis, lupus, and gout — affect an estimated 54 million adults in the United States according to the Centers for Disease Control and Prevention (CDC), making access to specialized care a significant public health concern. This page maps the professional landscape, selection criteria, consultation preparation, and reduced-cost pathways for rheumatologic care.

Types of professional assistance

Rheumatologic care involves a structured hierarchy of clinical professionals, each with distinct training boundaries and referral roles.

Board-certified rheumatologists represent the primary specialist category. These physicians complete internal medicine or pediatric residencies followed by a minimum 2-year accredited rheumatology fellowship, as defined by the Accreditation Council for Graduate Medical Education (ACGME). Certification is issued by the American Board of Internal Medicine (ABIM) through a subspecialty examination. Rheumatologists manage diagnosis and pharmacologic treatment of autoimmune, inflammatory, and musculoskeletal conditions. A full breakdown of training pathways appears at Rheumatology Board Certification.

Pediatric rheumatologists hold separate subspecialty certification through the American Board of Pediatrics (ABP) and focus exclusively on conditions such as juvenile idiopathic arthritis and pediatric lupus. The Pediatric Rheumatology specialty page describes this scope further.

Advanced Practice Providers (APPs) — including nurse practitioners (NPs) and physician assistants (PAs) — frequently manage established rheumatology patients in collaborative practice models under supervising physician oversight, as structured by state-level scope-of-practice statutes.

Physical and occupational therapists address functional deficits caused by joint disease. These clinicians operate under licensure requirements set by individual state licensing boards and treat areas including joint protection techniques and exercise with autoimmune disease.

Primary care physicians (PCPs) — family medicine and internal medicine practitioners — typically initiate the diagnostic workup, order blood tests for autoimmune disease, and coordinate referrals. A PCP's role is to rule out non-rheumatologic causes before or alongside specialist involvement.

The contrast between rheumatologists and orthopedic surgeons is a common decision point: rheumatologists manage medical (non-surgical) treatment of inflammatory joint disease, while orthopedic surgeons address structural repair. The Rheumatology vs. Orthopedics page defines these boundaries in detail.

How to identify the right resource

Selecting the appropriate professional begins with symptom classification. The American College of Rheumatology (ACR) publishes classification criteria for more than 20 distinct rheumatic conditions, and primary care providers use these frameworks when deciding whether specialist referral is warranted.

A structured approach to resource identification follows this sequence:

1. Document symptom onset, duration, and pattern — morning stiffness lasting more than 45 minutes, symmetric joint swelling, or unexplained fatigue and muscle pain each carry clinical weight in the referral decision.
2. Obtain initial laboratory screening — a PCP can order a complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), antinuclear antibody (ANA), and rheumatoid factor with anti-CCP panel before a specialist appointment.
3. Request a rheumatology referral — most insurance plans, including Medicare Part B, require a documented clinical indication for specialist referral. The rheumatology homepage at rheumatologyauthority.com provides condition-level overviews that can support informed conversations with referring providers.
4. Verify board certification — the ABIM Foundation maintains a public physician lookup tool at abim.org that allows verification of current certification status, including any lapsed or revoked credentials.
5. Confirm subspecialty fit — patients with overlapping connective tissue disease, vasculitis, or rare conditions such as scleroderma or Sjögren's syndrome may require referral to academic medical centers where subspecialty expertise is concentrated.

Geographic access is a documented barrier: the ACR Workforce Study (published 2015, with subsequent updates) identified a shortage of approximately 4,500 rheumatologists in the United States relative to projected demand by 2030. Telemedicine platforms credentialed through state medical boards now extend rheumatologic consultation to rural and underserved areas under coverage rules that expanded following CMS regulatory guidance.

What to bring to a consultation

The efficiency and diagnostic yield of a rheumatology consultation depend heavily on documentation brought by the patient or transferred from referring providers.

A complete consultation preparation checklist includes:

• Prior laboratory results — all ANA panels, complete metabolic panels, complete blood counts, and uric acid levels from the preceding 12 months
• Imaging records — X-rays, MRI, or ultrasound studies in DICOM format on CD or via secure transfer; relevant imaging modalities for rheumatic disease are detailed at Imaging in Rheumatic Disease
• Medication list — including over-the-counter NSAIDs, supplements, and corticosteroids, given their potential to mask inflammatory markers
• Family history documentation — first-degree relatives with autoimmune disease, as detailed at Family History and Autoimmune Screening
• Symptom diary — a written log noting joint distribution, time of day, severity scale, and any triggering activities
• Insurance documentation — prior authorization requirements for biologic therapies and DMARDs are often initiated at the first appointment

The Rheumatologic Examination page describes what clinicians assess during the physical examination, which helps patients understand why a thorough history is critical to accurate diagnosis.

Free and low-cost options

Financial barriers are clinically significant in rheumatology because first-line biologic therapies — including TNF inhibitors — carry average annual list prices exceeding $20,000 per patient according to published analyses in the American Journal of Managed Care.

Manufacturer patient assistance programs (PAPs) — Major biologic manufacturers including AbbVie (HUMIRA Complete), Amgen (AMGEN Assist 360), and Janssen (Janssen CarePath) operate federally reported assistance programs that can reduce or eliminate out-of-pocket costs for qualifying patients. Income thresholds and documentation requirements vary by program.

NeedyMeds — A 501(c)(3) nonprofit database at needymeds.org cataloging PAPs, disease-specific foundations, and free clinic locations by zip code across all 50 states.

The Arthritis Foundation — A named nonprofit organization providing disease-specific educational resources, local support group networks, and financial navigation assistance. The Foundation's Drug Assistance Program database cross-references manufacturer and foundation programs.

Federally Qualified Health Centers (FQHCs) — The Health Resources and Services Administration (HRSA) designates FQHCs under Section 330 of the Public Health Service Act. These centers provide sliding-scale fee structures based on household income and federal poverty guidelines. The HRSA health center finder at findahealthcenter.hrsa.gov locates facilities by address.

Medicaid coverage — All state Medicaid programs cover rheumatology specialist visits and most immunosuppressive medications, though prior authorization processes for biologics vary significantly by state formulary. CMS publishes Medicaid formulary requirements through its Medicaid Drug Rebate Program documentation.

340B Drug Pricing Program — Qualifying nonprofit hospitals and FQHCs can access medications at reduced prices under the 340B program, administered by HRSA's Office of Pharmacy Affairs. Patients receiving care at 340B-covered entities may access substantial savings on rheumatologic medications without separate application processes.

Academic medical center rheumatology divisions — including those affiliated with university hospitals — frequently operate reduced-cost or research-subsidized clinics for patients with rare or complex rheumatic disease, where participation in observational studies may accompany clinical care under institutional IRB protocols.

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)